OPK-88004

· OPKO Health, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OPK-88004, covering 2021-07-28 to 2021-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) [Phase 2]

See pricing